It has been reported that miR-137 induces differentiation of brain tumor stem cells and inhibits proliferation of GBM cells by post-transcriptional repression of cyclin-dependent kinase 6 (CDK6) (34). The gene discussed is CDK6; the disease is brain neoplasm.